Depression, Medication Adherence, and Service Utilization in Systemic Lupus Erythematosus

Overview

Journal Arthritis Rheum

Specialty Rheumatology

Date 2009 Jan 30

PMID 19177526

Citations 88

Authors

Laura J Julian

Edward Yelin

Jinoos Yazdany

Pantelis Panopalis

Laura Trupin

Lindsey A Criswell

Patricia Katz

Affiliations

Soon will be listed here.

Abstract

Objective: Forgetting to take medications is an important cause of nonadherence. This study evaluated factors associated with forgetting to take medications in a large cohort of persons with systemic lupus erythematosus (SLE) participating in the University of California, San Francisco Lupus Outcomes Study (LOS). Relationships among adherence problems and service utilization (outpatient visits, emergency department visits, and hospitalizations) were also evaluated.

Methods: The cohort consisted of 834 LOS participants who provided self-reported frequency of forgetting to take medications as directed. Predictors of adherence and service utilization patterns included self-reported sociodemographics, disease-related characteristics (e.g., disease activity, recent SLE flare), and mental health characteristics (Center for Epidemiologic Studies Depression Scale and cognitive function screen). Health care utilization patterns included the presence and quantity of visits to rheumatologists, primary care physicians, other care providers, emergency departments, and hospitalizations.

Results: Forty-six percent of the LOS cohort reported forgetting to take medications at least some of the time. Depressive symptom severity was a strong predictor of adherence difficulties (odds ratio [OR] 1.04, 95% confidence interval [95% CI] 1.02-1.05; P < 0.0001) after accounting for all other predictors. Persons reporting adherence difficulties had significantly greater numbers of outpatient rheumatology and primary care visits, and were more likely to visit the emergency department (OR 1.45, 95% CI 1.04-2.04; P = 0.03).

Conclusion: Depression may be an important cause of medication adherence problems, and difficulties with adherence are significantly associated with high-cost service utilization, specifically emergency department visits. In an era of rapidly evolving treatments for lupus, identifying patients at risk for adherence problems may decrease medical expenditures and improve patient outcomes in SLE.

Citing Articles

The unique challenges of childhood-onset systemic lupus erythematosus and lupus nephritis patients: a proposed framework for an individualized transitional care plan.

Renson T, Lightstone L, Ciurtin C, Gaymer C, Marks S Pediatr Nephrol. 2025; .

PMID: 40080183 DOI: 10.1007/s00467-024-06654-5.

Socioeconomic status, reserve capacity, and depressive symptoms predict pain in Rheumatoid Arthritis: an examination of the reserve capacity model.

Azizoddin D, Olmstead R, Anderson K, Hirz A, Irwin M, Gholizadeh S BMC Rheumatol. 2024; 8(1):46.

PMID: 39304956 PMC: 11414099. DOI: 10.1186/s41927-024-00416-4.

"Lupus Doesn't Have Me, I Have Lupus": Using Patient-Centered Interviews to Understand Medication Nonadherence.

Macko C, Santos R, Ramalingam N, Tran N, Zheng S, Chen P Perm J. 2024; 28(3):84-90.

PMID: 39042384 PMC: 11404647. DOI: 10.7812/TPP/23.161.

Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey.

Emamikia S, Gomez A, Adahl T, von Perner G, Enman Y, Chatzidionysiou K Lupus. 2024; 33(6):615-628.

PMID: 38545763 PMC: 11015713. DOI: 10.1177/09612033241242692.

One-Year Outcomes for Depression and Anxiety in SLE Patients.

Duca L, Roman N, Ifteni P, Teodorescu A Biomedicines. 2024; 12(3).

PMID: 38540098 PMC: 10968247. DOI: 10.3390/biomedicines12030484.

References

Yazdany J, Yelin E, Panopalis P, Trupin L, Julian L, Katz P . Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum. 2008; 59(1):136-43. PMC: 3759159. DOI: 10.1002/art.23238. View

Mosley-Williams A, Lumley M, Gillis M, Leisen J, Guice D . Barriers to treatment adherence among African American and white women with systemic lupus erythematosus. Arthritis Rheum. 2003; 47(6):630-8. DOI: 10.1002/art.10790. View

Sokol M, McGuigan K, Verbrugge R, Epstein R . Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005; 43(6):521-30. DOI: 10.1097/01.mlr.0000163641.86870.af. View

Bernatsky S, Boivin J, Joseph L, Manzi S, Ginzler E, Gladman D . Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006; 54(8):2550-7. DOI: 10.1002/art.21955. View

Schroeder K, Fahey T, Hay A, Montgomery A, Peters T . Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol. 2006; 59(6):650-1. DOI: 10.1016/j.jclinepi.2005.10.013. View

Adler M, Chambers S, Edwards C, Neild G, Isenberg D . An assessment of renal failure in an SLE cohort with special reference to ethnicity, over a 25-year period. Rheumatology (Oxford). 2006; 45(9):1144-7. DOI: 10.1093/rheumatology/kel039. View

Yelin E, Trupin L, Katz P, Criswell L, Yazdany J, Gillis J . Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum. 2007; 57(1):56-63. PMC: 2875125. DOI: 10.1002/art.22481. View

Spector S, Kinsman R, Mawhinney H, SIEGEL S, Rachelefsky G, Katz R . Compliance of patients with asthma with an experimental aerosolized medication: implications for controlled clinical trials. J Allergy Clin Immunol. 1986; 77(1 Pt 1):65-70. DOI: 10.1016/0091-6749(86)90325-8. View

Rojas-Serrano J, Cardiel M . Lupus patients in an emergency unit. Causes of consultation, hospitalization and outcome. A cohort study. Lupus. 2000; 9(8):601-6. DOI: 10.1191/096120300678828785. View

10.

Norell S . Accuracy of patient interviews and estimates by clinical staff in determining medication compliance. Soc Sci Med E. 1981; 15(1):57-61. DOI: 10.1016/0271-5384(81)90063-6. View

11.

Burra T, Chen E, McIntyre R, Grace S, Robertson Blackmore E, Stewart D . Predictors of self-reported antidepressant adherence. Behav Med. 2007; 32(4):127-34. DOI: 10.3200/BMED.32.4.127-134. View

12.

Lew K, Chang E, Rajagopalan K, Knoth R . The effect of medication adherence on health care utilization in bipolar disorder. Manag Care Interface. 2006; 19(9):41-6. View

13.

Rieckmann N, Kronish I, Haas D, Gerin W, Chaplin W, Burg M . Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J. 2006; 152(5):922-7. DOI: 10.1016/j.ahj.2006.05.014. View

14.

Rand C . Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol. 1993; 72(10):68D-74D. DOI: 10.1016/0002-9149(93)90014-4. View

15.

Petri M, Perez-Gutthann S, Longenecker J, Hochberg M . Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med. 1991; 91(4):345-53. DOI: 10.1016/0002-9343(91)90151-m. View

16.

Barclay T, Hinkin C, Castellon S, Mason K, Reinhard M, Marion S . Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol. 2007; 26(1):40-9. PMC: 2863998. DOI: 10.1037/0278-6133.26.1.40. View

17.

Gehi A, Haas D, Pipkin S, Whooley M . Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med. 2005; 165(21):2508-13. PMC: 2776695. DOI: 10.1001/archinte.165.21.2508. View

18.

Zeller A, Schroeder K, Peters T . An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008; 61(3):282-8. DOI: 10.1016/j.jclinepi.2007.04.007. View

19.

Hochberg M . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9):1725. DOI: 10.1002/art.1780400928. View

20.

Mohr D, Goodkin D, Likosky W, Gatto N, Baumann K, Rudick R . Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol. 1997; 54(5):531-3. DOI: 10.1001/archneur.1997.00550170015009. View